Diurnal changes and topographical distribution of ocular surface epithelial dendritic cells in humans, and repeatability of density and morphology assessment - Tajbakhsh, Zahra; Jalbert, Isabelle; Stapleton, Fiona; Briggs, Nancy; Golebiowski, Blanka (medRxiv, 2022)
Purpose Dendritic cells (DC) play a crucial role in ocular surface defence. DC can be visualised in vivo by confocal microscopy but have not yet been fully characterised in humans. This study investigated the diurnal variation, topographical distribution, and repeatability of DC density and morphology measurement.Methods In vivo confocal microscopy was conducted on 20 healthy participants (mean age 32.7±6.4 years, 50% F) at baseline and repeated after 30 minutes, 2, 6, and 24 hours. Images were captured at the corneal centre, inferior whorl, corneal periphery, limbus, and bulbar conjunctiva. DC density was counted manually, and morphology of DC was assessed for the largest cell body size, presence of dendrites, presence of long dendrites, and presence of thick dendrites. Mixed model analysis, non-parametric analyses, Bland & Altman plots, the Coefficient of Repeatability (CoR), and kappa were used.Results There were no significant changes in DC density (p≥0.74) or morphology (p>0.07) at any location over the 24-hour period. Highest DC density was observed at the corneal limbus followed by the peripheral cornea (p<0.001), with lowest density at the corneal centre, inferior whorl, and bulbar conjunctiva. Most DC at the corneal periphery, limbus, and bulbar conjunctiva had larger cell bodies compared to the corneal centre (p≤0.01), and presence of long dendrites was observed mostly at non-central locations. DC with thick dendrites were mostly observed at the limbus. Day-to-day CoR for DC density ranged from ±28.1 cells/mm2 at the corneal centre to ±56.4 cells/mm2 at the limbus. Day-to-day agreement of DC morphology determined by kappa ranged from 0.5 to 0.95 for cell body size, 0.60 to 0.95 for presence of dendrites, and 0.55 to 0.80 for presence of long dendrites, at various locations.Conclusions No diurnal changes are apparent in corneal or conjunctival DC. Substantial topographical differences exist in DC density and morphology. In vivo confocal microscopy provides good repeatability of DC density and acceptable agreement of DC morphology.Key pointsThere was no diurnal variation in dendritic cell density, morphology, or topographical distribution at the ocular surface in healthy individuals.A gradient from high density of dendritic cells at the limbus to low density at the corneal centre was observed in in vivo confocal microscope images of healthy corneas. Density was lowest in the bulbar conjunctiva.The morphology of dendritic cells at the corneal periphery, limbus and bulbar conjunctiva suggests a greater antigen capture capacity compared to dendritic cells at the corneal centre.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Human Research Ethics Committee of University of New South Wales Sydney.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.